Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma

Nature Communications

Volumn 4, Issue , 2013, Pages

  Frampton, Matthew ^a   Da Silva Filho, Miguel Inacio ^b   Broderick, Peter ^a   Thomsen, Hauke ^b   Försti, Asta ^b,c   Vijayakrishnan, Jayaram ^a   Cooke, Rosie ^a   Enciso Mora, Victor ^a   Hoffmann, Per ^d,e   Nöthen, Markus M ^d,f   Lloyd, Amy ^a   Holroyd, Amy ^a   Eisele, Lewin ^g   Jöckel, Karl Heinz ^g   Ponader, Sabine ^h   Von Strandmann, Elke Pogge ^h   Lightfoot, Tracy ⁱ   Roman, Eve ⁱ   Lake, Annette ^j   Montgomery, Dorothy ^j   Jarrett, Ruth F ^j   Swerdlow, Anthony J ^a   Engert, Andreas ^h   Hemminki, Kari ^b,c   Houlston, Richard S ^a   more..

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c LUND UNIVERSITY   (Sweden)

^d UNIVERSITY OF BONN   (Germany)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^g UNIVERSITY OF DUISBURG ESSEN   (Germany)

^h UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

ⁱ UNIVERSITY OF YORK   (United Kingdom)

^j MRC UNIVERSITY OF GLASGOW CENTRE FOR VIRUS RESEARCH   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

BLOOD; CANCER; GENETIC ANALYSIS; GENOME; RISK ASSESSMENT;

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENOTYPE; HEMATOPOIESIS; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 6; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE EXPRESSION; GENE FREQUENCY; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HODGKIN DISEASE; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; T-BOX DOMAIN PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84886709919     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms3549     Document Type: Article

References (42)

1. Kuppers, R. The biology of Hodgkin's lymphoma. Nat. Rev. Cancer 9, 15-27 (2009).
2. Hjalgrim, H. & Engels, E. A. Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: A review of the epidemiological evidence. J. Intern. Med. 264, 537-548 (2008).
3. Mack, T. M. et al. Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N. Engl. J. Med. 332, 413-418 (1995).
4. Cozen, W. et al. A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32. Blood 119, 469-475 (2011).
5. Urayama, K. Y. et al. Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. J. Natl Cancer Inst. 104, 240-253 (2012).
6. Moutsianas, L. et al. Multiple Hodgkin lymphoma-associated loci within the HLA region at chromosome 6p21.3. Blood 118, 670-674 (2012).
7. Enciso-Mora, V. et al. A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). Nat. Genet. 42, 1126-1130 (2011).
8. Clayton, D. G. et al. Population structure, differential bias and genomic control in a large-scale, case-control association study. Nat. Genet. 37, 1243-1246 (2005). (Pubitemid 41568707)
9. Bandele, O. J., Wang, X., Campbell, M. R., Pittman, G. S. & Bell, D. A. Human single-nucleotide polymorphisms alter p53 sequence-specific binding at gene regulatory elements. Nucleic Acids Res. 39, 178-189 (2010).
10. Zhang, S., Li, T., Zhang, B., Nong, L. & Aozasa, K. Transcription factors engaged in development of NK cells are commonly expressed in nasal NK/Tcell lymphomas. Hum. Pathol. 42, 1319-1328 (2011).
11. Liu, Y., Sattarzadeh, A., Diepstra, A., Visser, L. & van den Berg, A. The microenvironment in classical Hodgkin lymphoma: An actively shaped and essential tumor component. Semin. Cancer Biol. doi:10.1016/j.semcancer.2013.07. 002 (2013).
12. Atayar, C. et al. Expression of the T-cell transcription factors, GATA-3 and T-bet, in the neoplastic cells of Hodgkin lymphomas. Am. J. Pathol. 166, 127-134 (2005). (Pubitemid 40051666)
13. Pearce, E. L. et al. Control of effector CD8? T cell function by the transcription factor Eomesodermin. Science 302, 1041-1043 (2003). (Pubitemid 37386196)
14. Intlekofer, A. M. et al. Anomalous type 17 response to viral infection by CD8? T cells lacking T-bet and eomesodermin. Science 321, 408-411 (2008). (Pubitemid 352029977)
15. Paley, M. A. et al. Progenitor and terminal subsets of CD8? T cells cooperate to contain chronic viral infection. Science 338, 1220-1225 (2012).
16. Endo, Y. et al. Eomesodermin controls interleukin-5 production in memory T helper 2 cells through inhibition of activity of the transcription factor GATA3. Immunity 35, 733-745 (2011).
17. Sawcer, S. et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476, 214-219 (2011).
18. Landgren, O. et al. Re: familial clustering of Hodgkin lymphoma and multiple sclerosis. J. Natl Cancer Inst. 97, 543-544 author reply 544-545 (2005).
19. Gieger, C. et al. New gene functions in megakaryopoiesis and platelet formation. Nature 480, 201-208 (2011).
20. Okada, Y. et al. Identification of nine novel loci associated with white blood cell subtypes in a Japanese population. PLoS Genet. 7, e1002067 (2011).
21. van der Harst, P. et al. Seventy-five genetic loci influencing the human red blood cell. Nature 492, 369-375 (2012).
22. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678 (2007).
23. Power, C. & Elliott, J. Cohort profile: 1958 British birth cohort (National Child Development Study). Int. J. Epidemiol. 35, 34-41 (2006). (Pubitemid 43205440)
24. Penegar, S. et al. National study of colorectal cancer genetics. Br. J. Cancer 97, 1305-1309 (2007). (Pubitemid 350035800)
25. Purcell, S. et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575 (2007). (Pubitemid 47330214)
26. Mantel, N. & Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl Cancer Inst. 22, 719-748 (1959).
27. DerSimonian, R. & Laird, N. Meta-analysis in clinical trials. Control Clin. Trials 7, 177-188 (1986). (Pubitemid 17189972)
28. Higgins, J. P. & Thompson, S. G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 1539-1558 (2002). (Pubitemid 34746062)
29. Goldin, L. R., Bjorkholm, M., Kristinsson, S. Y., Turesson, I. & Landgren, O. Highly increased familial risks for specific lymphoma subtypes. Br. J. Haematol. 146, 91-94 (2009).
30. Wray, N. R., Yang, J., Goddard, M. E. & Visscher, P. M. The genetic interpretation of area under the ROC curve in genomic profiling. PLoS Genet. 6, e1000864 (2010).
31. Howie, B. N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009).
32. Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 39, 906-913 (2007). (Pubitemid 47014502)
33. Johnson, A. D. et al. SNAP: A web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24, 2938-2939 (2008).
34. Myers, S., Bottolo, L., Freeman, C., McVean, G. & Donnelly, P. A fine-scale map of recombination rates and hotspots across the human genome. Science 310, 321-324 (2005). (Pubitemid 41457199)
35. Gabriel, S. B. et al. The structure of haplotype blocks in the human genome. Science 296, 2225-2229 (2002). (Pubitemid 34680308)
36. Ernst, J. & Kellis, M. Discovery and characterization of chromatin states for systematic annotation of the human genome. Nat. Biotechnol. 28, 817-825 (2010).
37. Boyle, A. P. et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 22, 1790-1797 (2012).
38. Ward, L. D. & Kellis, M. HaploReg: A resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 40, D930-D934 (2012).
39. Dimas, A. S. et al. Common regulatory variation impacts gene expression in a cell type-dependent manner. Science 325, 1246-1250 (2009).
40. Nica, A. C. et al. The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS Genet. 7, e1002003 (2011).
41. Stranger, B. E. et al. Patterns of cis regulatory variation in diverse human populations. PLoS Genet. 8, e1002639 (2012).
42. Enciso-Mora, V. et al. A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). Nat. Genet. 42, 1126-1130 (2010).